Estimating the Fitness Cost of Escape from HLA Presentation in HIV-1 Protease and Reverse Transcriptase

Human immunodeficiency virus (HIV-1) is, like most pathogens, under selective pressure to escape the immune system of its host. In particular, HIV-1 can avoid recognition by cytotoxic T lymphocytes (CTLs) by altering the binding affinity of viral peptides to human leukocyte antigen (HLA) molecules, the role of which is to present those peptides to the immune system. It is generally assumed that HLA escape mutations carry a replicative fitness cost, but these costs have not been quantified. In this study, we assess the replicative cost of mutations which are likely to escape presentation by HLA molecules in the region of HIV-1 protease and reverse transcriptase. Specifically, we combine computational approaches for prediction of in vitro replicative fitness and peptide binding affinity to HLA molecules. We find that mutations which impair binding to HLA-A molecules tend to have lower in vitro replicative fitness than mutations which do not impair binding to HLA-A molecules, suggesting that HLA-A escape mutations carry higher fitness costs than non-escape mutations. We argue that the association between fitness and HLA-A binding impairment is probably due to an intrinsic cost of escape from HLA-A molecules, and these costs are particularly strong for HLA-A alleles associated with efficient virus control. Counter-intuitively, we do not observe a significant effect in the case of HLA-B, but, as discussed, this does not argue against the relevance of HLA-B in virus control. Overall, this article points to the intriguing possibility that HLA-A molecules preferentially target more conserved regions of HIV-1, emphasizing the importance of HLA-A genes in the evolution of HIV-1 and RNA viruses in general.

[1]  Louis J. Picker,et al.  New paradigms for HIV/AIDS vaccine development. , 2012, Annual review of medicine.

[2]  HIV prevalence estimates--United States, 2006. , 2008, MMWR. Morbidity and mortality weekly report.

[3]  D. van Baarle,et al.  HLA-B molecules target more conserved regions of the HIV-1 proteome , 2010, AIDS.

[4]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[5]  Christian L. Althaus,et al.  Dynamics of Immune Escape during HIV/SIV Infection , 2008, PLoS Comput. Biol..

[6]  D. Heckerman,et al.  HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 , 2011, The Journal of Immunology.

[7]  P. Klenerman,et al.  Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection , 2011, Gut.

[8]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[9]  K. Koelle,et al.  Capturing escape in infectious disease dynamics. , 2008, Trends in ecology & evolution.

[10]  B. Berkhout,et al.  Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic , 2011, AIDS.

[11]  Becca Asquith,et al.  Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.

[12]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[13]  Angela R. McLean,et al.  Modelling the Evolution and Spread of HIV Immune Escape Mutants , 2010, PLoS pathogens.

[14]  D. Barouch,et al.  Challenges in the development of an HIV-1 vaccine , 2008, Nature.

[15]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[16]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[17]  Y. Louzoun,et al.  The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire , 2009, AIDS.

[18]  Charles R. M. Bangham,et al.  T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules , 2009, PLoS Comput. Biol..

[19]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[20]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  O. Lund,et al.  NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.

[22]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[23]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[24]  B. Schmidt,et al.  Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease , 2007, Journal of Virology.

[25]  Morten Nielsen,et al.  MHC motif viewer , 2008, Immunogenetics.

[26]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[27]  Eric J. Arts,et al.  Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.

[28]  P. van Endert,et al.  Differential proteasomal processing of hydrophobic and hydrophilic protein regions: Contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Sebastian Bonhoeffer,et al.  A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase , 2011, Nature Genetics.

[30]  Becca Asquith,et al.  In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques , 2007, Proceedings of the National Academy of Sciences.

[31]  Steven M. Wolinsky,et al.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.

[32]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[33]  H. Blum,et al.  Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine , 2008, Biological chemistry.

[34]  D. van Baarle,et al.  A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses1 , 2009, The Journal of Immunology.

[35]  J. Margolick,et al.  Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals , 2008, Journal of Virology.

[36]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[37]  John Sidney,et al.  Impact of HLA-B Alleles, Epitope Binding Affinity, Functional Avidity, and Viral Coinfection on the Immunodominance of Virus-Specific CTL Responses1 , 2006, The Journal of Immunology.

[38]  Katrina Walsh,et al.  Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.

[39]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[40]  J. Calis,et al.  MHC class I molecules exploit the low G+C content of pathogen genomes for enhanced presentation , 2010, European journal of immunology.

[41]  J. Meek Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Carrington,et al.  HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.

[43]  A. Folgori,et al.  Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection , 2005, European journal of immunology.

[44]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[45]  David Heckerman,et al.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.

[46]  Marc Lipsitch,et al.  Patterns of antigenic diversity and the mechanisms that maintain them , 2007, Journal of The Royal Society Interface.

[47]  Sergei L. Kosakovsky Pond,et al.  Adaptation to Human Populations Is Revealed by Within-Host Polymorphisms in HIV-1 and Hepatitis C Virus , 2007, PLoS pathogens.

[48]  L. Loh,et al.  Rates of HIV immune escape and reversion: implications for vaccination. , 2008, Trends in microbiology.

[49]  Huldrych F. Günthard,et al.  Assessing Predicted HIV-1 Replicative Capacity in a Clinical Setting , 2011, PLoS pathogens.

[50]  Morten Nielsen,et al.  Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods , 2009, Bioinform..

[51]  Huldrych F Günthard,et al.  2011 update of the drug resistance mutations in HIV-1. , 2011, Topics in antiviral medicine.

[52]  N. Wexler Huntington's disease: advocacy driving science. , 2012, Annual review of medicine.

[53]  B. Walker,et al.  Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.

[54]  Philip J. R. Goulder,et al.  Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.

[55]  Loren Gragert,et al.  High-resolution HLA alleles and haplotypes in the United States population. , 2007, Human immunology.

[56]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[57]  Derek J Smith,et al.  Predictability and Preparedness in Influenza Control , 2006, Science.

[58]  Todd M. Allen,et al.  Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[59]  Christos J. Petropoulos,et al.  A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1 , 2000, Antimicrobial Agents and Chemotherapy.

[60]  C. Walker,et al.  Mutational escape from CD8+ T cell immunity , 2005, The Journal of experimental medicine.

[61]  Nicole Frahma,et al.  HIV Molecular Immunology 2005 , 2006 .

[62]  Austin L. Hughes,et al.  Self peptides bound by HLA class I molecules are derived from highly conserved regions of a set of evolutionarily conserved proteins , 2004, Immunogenetics.

[63]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[64]  Ron A M Fouchier,et al.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. , 2008, Vaccine.

[65]  Sebastian Bonhoeffer,et al.  The Role of Recombination for the Coevolutionary Dynamics of HIV and the Immune Response , 2011, PloS one.

[66]  Todd M. Allen,et al.  Understanding cytotoxic T‐lymphocyte escape during simian immunodeficiency virus infection , 2001, Immunological reviews.

[67]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[68]  Nebojsa Jojic,et al.  Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins , 2010, Journal of Virology.

[69]  Tao Dong,et al.  Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope , 2006, Nature Immunology.

[70]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[71]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[72]  Todd M. Allen,et al.  Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A , 2007, Journal of Virology.

[73]  Yi Liu,et al.  Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection , 2011, PloS one.

[74]  Edward C Holmes,et al.  Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies. , 2004, The Journal of infectious diseases.

[75]  Stephen J O'Brien,et al.  The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.

[76]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.